Bizarre Patents
A portable partition for use in an automobile having a seat with a seat bench and a seat backrest.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120128843 | WATER AND FEED PRESERVATIVE Antimicrobial compositions containing buffered propionic or acetic acid mixed with pelargonic acid.... | 05/24/2012 |
| 20120128724 | SYSTEMS AND METHODS FOR TREATING HUMAN INFLAMMATORY AND PROLIFERATIVE DISEASES AND WOUNDS, WITH FATTY ACID METABOLISM INHIBITORS AND/OR GLYCOLYTIC INHIBITORS Systems and methods for treating inflammatory and proliferative diseases, and wounds, using as a pharmacon a fatty acid metabolism inhibitor, a glycolytic inhibitor, and/or an agent able to alter cellular production of reactive oxygen, or combination thereof, optionally... | 05/24/2012 |
| 20120129935 | NUTRITION WITH LIPIDS AND NON-DIGESTIBLE SACCHARIDES The invention relates to a liquid nutrition comprising short chain fatty acyl chains and a non-digestible, fermentable saccharide. The composition is particular suitable for use as an infant nutrition. The composition is also suitable for treatment and/or prevention of ... | 05/24/2012 |
| 20120107415 | COMBINED DISINFECTION AND DECONTAMINATION AGENT HAVING INCREASED EFFECTIVENESS The invention relates to a novel combined disinfection and decontamination agent comprising at least one vitamin, at least one metal ion, at least one active-surface compound, and at least one further antimicrobial active substance. The agent according to the invention ... | 05/03/2012 |
| 20120107414 | PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING RESPIRATORY TRACT INFECTIONS The present invention relates to pharmaceutical formulations for treating a respiratory tract infection or a pulmonary disease in an individual, comprising a calcium salt and a sodium salt, wherein the ratio of Ca+2 to Na+ is from about 4:1 (mole:m... | 05/03/2012 |
| 20120082742 | METHOD AND COMPOSITIONS FOR TREATING CUTANEOUS VERRUCAE By incorporating certain pharmaceutical and cosmetic preservative agents into nail polish vehicles containing corrosive ingredients, the risk and prevalence of recurrence of verrucae can be substantially reduced.... | 04/05/2012 |
| 20120083531 | CALCIUM CITRATE AND CALCIUM LACTATE FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING The present invention relates to pharmaceutical compositions suitable for inhalation, comprising as an active ingredient calcium lactate or calcium citrate. The invention also relates to methods of treating, preventing, and reducing the spread of an infection of the res... | 04/05/2012 |
| 20120071548 | Therapeutic compositions Compositions comprising ketone bodies and/or their metabolic precursors are provided that are suitable for administration to humans and animals and which have the properties of, inter alia, (i) increasing cardiac efficiency, particularly efficiency in use of glucose, (i... | 03/22/2012 |
| 20120071557 | ANIMAL FEED COMPOSITIONS OF ABSCISIC ACID The invention relates to compositions comprising abscisic acid, and/or salts, and derivatives thereof, and methods of using the same for improving the health, growth, and feed efficiency of livestock and fish as well as the quantity of meat produced in livestock in part... | 03/22/2012 |
| 20120070476 | Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces The present disclosure includes compositions and methods of inactivating pathogens of a genital tract of a female. The compositions include L-lactic acid substantially free of D-lactic acid. In particular, an intravaginal ring for sustained release of L-lactic acid out ... | 03/22/2012 |
| 20120070497 | USE OF BOSWELLIC ACIDS FOR THE PROPHYLAXIS AND/OR TREATMENT OF DAMAGE TO AND/OR INFLAMMATION OF THE ISLETS OF LANGERHANS Disclosed are methods and compositions related to the use of boswellic acids (such as acetyl-11-keto-β-boswellic acid, 11-keto-β-boswellic acid, β-boswellic acid, acetyl-β-boswellic acid, 9,11-dehydro-β-boswellic acid, acetyl-9,11-dehydro-β-boswellic acid, α-bosw... | 03/22/2012 |
| 20120070400 | METHOD FOR IMPROVING THE MILDNESS OF CLEANSING COMPOSITIONS A method for improving the mildness of a cleansing composition includes 0.1 to 15 wt. % of a combination of a lactate salt and a gluconate salt is provided in a cleansing composition comprising 4-55 wt. % of a surfactant and water, wherein the lactate salt makes up 10-9... | 03/22/2012 |
| 20120071556 | PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS OF ABSCISIC ACID The invention relates to compositions comprising abscisic acid, and/or salts, derivatives and analogs thereof, and methods of pharmaceutical and/or nutraceutical use.... | 03/22/2012 |
| 20120070417 | ANTI-INFLUENZA FORMULATIONS AND METHODS The invention relates to pharmaceutical compositions that contain a calcium salt as an active ingredient and also comprise another anti-influenza agent, and to methods for treating or preventing influenza virus infection. ... | 03/22/2012 |
| 20120071555 | COMPOSITIONS OF ABSCISIC ACID FOR ANIMAL HEALTH The invention relates to compositions comprising abscisic acid, and/or salts, derivatives and analogs thereof, and methods of using the same for improving the health and offspring mortality of animals.... | 03/22/2012 |
| 20120071417 | METHODS OF INHIBITING CANCER CELL GROWTH WITH HDAC INHIBITORS AND METHODS OF SCREENING FOR HDAC10 INHIBITORS Methods of inhibiting cancer cell growth using HDAC10 inhibitors are provided. Methods of treating cancer in a subject using HDAC10 inhibitors are also provided. In certain embodiments, at least one second inhibitor selected from an autophagy inhibitor, an AMPK inhibito... | 03/22/2012 |
| 20120071554 | DEUTERATED 2-PROPYLPENTANOIC ACID COMPOUNDS Described herein are novel analogs of 2-propylpentanoic acid, pharmaceutical compositions comprising the same, and methods of using the same for the treatment of diseases or conditions that are beneficially treated by administering a GABAAergic transmission enhancer and... | 03/22/2012 |
| 20120071432 | CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS The present invention concerns compositions, methods and/or apparatus of central administration of various CNS-ac-Live agents. In particular embodiments, intrathecal administration is advantageous for decreasing the systemic concentrations of CNS agent, thereby decreasi... | 03/22/2012 |
| 20120070511 | MITOCHONDRIAL INHIBITORS AND USES THEREOF Compositions which modulate mitochondrial functions treat diseases associated with cells that are hyperactively using their endoplasmic reticulum. Screening assays identify agents which modulate mitochondrial functions.... | 03/22/2012 |
| 20120053152 | (R)-(-)-1,2-propanediol compositions and methods Short-chain 2- to 3-carbon alcohols are used as solvents for cooling agents in the preparation of topical therapeutic and cosmetic formulations. Some of these alcohols, especially ethanol, inhibit the ability of the cooling agent to activate its target receptor. In one ... | 03/01/2012 |
| 20120053141 | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis The present invention pertains to novel uses of glycyrrhetinic acid (GA), glycyrrhizic acid (GLA) and related compounds for prevention and/or treatment of pulmonary fibrosis, in particular, irradiation-induced pulmonary fibrosis. Also embodied are therapeutic uses of pr... | 03/01/2012 |
| 20120053240 | Method of Administering beta-hydroxy-beta-methylbutyrate (HMB) A method of administering beta-hydroxy-beta-methylbutyric acid (HMB) is described, and specifically administering HMB-acid to a person such that the administration of free acid HMB results in an increase in effectiveness of HMB over administration of other forms of HMB,... | 03/01/2012 |
| 20120052133 | Synergy of Strong Acids and Peroxy Compounds Disclosed is a method for improving decontamination in meat, poultry, fish, fruit and vegetable processing using a combination of acid(s) and peroxy compound(s). The method comprises a “stacked” approach, sequentially adding the acid(s) and peroxy compound(s) to an ... | 03/01/2012 |
| 20120053133 | ANTISEPTIC AGENT COMPOSITION A novel antiseptic agent composition which has a wide antimicrobial spectrum and excellent antiseptic properties is provided. An antiseptic agent composition A contains a glycerin hydroxy fatty acid monoester that is an ester of glycerin and a hydroxy fatty acid having ... | 03/01/2012 |
| 20120045532 | Anticancer Methods Employing Extracts of Gleditsia sinensis Lam Selective apoptotic extracts of Gleditsia sinensis Lam are provided. Also provided are methods of using said extracts to induce apoptosis in specific cells, especially in a human. Provided as well are uses of the extracts of Gleditsia sinensis Lam for the ... | 02/23/2012 |
| 20120045525 | MOSQUITO REPELLENT SOLUTION, PREPARATION METHOD AND USE THEREOF A mosquito repellent solution to prevent mosquito bite, comprising 0.1-9.9% organic acid of total weight as active principle, 88-99.6% water as solvent. The organic acid is single acid or mixed composition out of ethyl butyrate, propionic acid, n-butyric acid, isobutyri... | 02/23/2012 |
| 20120046252 | Calcium Formate for Use as a Dietary Supplement A calcium formate composition for oral administration to an individual for the purpose of supplementary dietary calcium is disclosed.... | 02/23/2012 |
| 20120039909 | EPIGENETIC MECHANISMS RE-ESTABLISH ACCESS TO LONG-TERM MEMORY AFTER NEURONAL LOSS The invention relates to methods and products for enhancing and improving recovery of lost memories. In particular the methods are accomplished through the increase of histone acetylation.... | 02/16/2012 |
| 20120035176 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID Analogs of 3-O-acetyl-11-keto-beta-boswellic acid and their method of preparation are presented. The analogs may be used as anti-inflammatory and anti-cancer agents. The compounds inhibit 5-lipoxygenase enzyme and various cell lines related to inflammation as well as to... | 02/09/2012 |
| 20120028957 | Inhibitors Of The Influenza A Virus M2 Proton Channel Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a compositio... | 02/02/2012 |
| 20120027693 | METHODS AND COMPOSITIONS FOR PREVENTING AND RELIEVING MUSCLE CRAMPS AND FOR RECOVERY FROM NEUROMUSCULAR IRRITABILITY AND FATIGUE FOLLOWING EXERCISE The methods and compositions of the present invention are directed to the treatment or amelioration of muscle cramps using a composition that includes one or more TRPV1 channel activators, and/or one or more TRPA1 channel activators, and/or one or more ASIC channel acti... | 02/02/2012 |
| 20120027879 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING METABOLIC DISORDERS Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention compri... | 02/02/2012 |
| 20120016025 | PERHYDROLASES FOR ENZYMATIC PERACID GENERATION Disclosed herein are variants enzymes that are structurally classified as CE-7 enzymes and have perhydrolysis activity. Also disclosed herein is a process for producing peroxycarboxylic acids from carboxylic acid esters using the aforementioned variant enzymes as well a... | 01/19/2012 |
| 20120014934 | Enhanced Natural Colors A natural color is concentrated to intensify color range and to provide useful amounts of one or more of anti-oxidant, nutritional, and anti-inflammatory compounds derived from one or more pigment sources. In a preferred embodiment, the pigment source is a fruit, a vege... | 01/19/2012 |
| 20120015012 | COSMETIC COMPOSITION CONTAINING KETOGLUCONIC ACID DERIVATIVES Cosmetic compositions containing at least one derivative of ketogluconic acid and use thereof as anti-ageing and skin restructuring agent.... | 01/19/2012 |
| 20120015809 | Materials and Methods for Pest Control The subject invention provides materials and methods for the control of pests, including fungi, oomycetes, nematodes, and weeds, of numerous crops, plants and forests. Advantageously, pests in the soil can be controlled without phytotoxicity. In certain embodiments, the... | 01/19/2012 |
| 20120009169 | SELF-FORMING PHOSPHOLIPIDIC GELS A phospholipid gel is spontaneously formed when combining a first phospholipid, a second phospholipid, and water, wherein the first phospholipid is a neutral phospholipid and the second phospholipid is a negatively charged phospholipid. The first and second phospholipid... | 01/12/2012 |
| 20120009243 | LIPOSOMES FOR DRUG DELIVERY AND METHODS FOR PREPARATION THEREOF The present invention provides liposomes that are useful for delivery of bioactive agents such as therapeutics. Among others, the liposomes of the invention are capable of delivering their payload at sites of increased secretory phospholipase A2 (sPLA2) activity, becaus... | 01/12/2012 |
| 20120004284 | PDK INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF The invention relates to methods of treating or preventing acquired or congenital mitochondrial diseases or disorders, including treating cell proliferation related disorders or diseases, such as cancer. The invention further relates to pharmaceutical compositions for t... | 01/05/2012 |
| 20120004291 | COMPANION ANIMAL COMPOSITIONS INCLUDING PYRUVIC ACID AND SALTS THEREOF AND METHODS OF USE THEREOF The invention encompasses pet food compositions and methods for the treatment and/or prevention of diseases or disorders in companion animals, for example, for the treatment or obesity, including administering a pet food composition including pyruvic acid or a salt ther... | 01/05/2012 |
